Braskem SA BAK
Major Chemicals · data as of November 13, 2026
Braskem SA (BAK) is a industrial company listed in the US with a market value of about $450M. In the twelve months to September 30, 2026 it had revenue of $12.9B and net income of -$1.2B, a net margin of -9.0%.
Its overall Stock Analiz score is 0.2 out of 5 (weak). The strongest part is value (1/5); the weakest is future growth (0/5).
Key numbers: 5-year revenue growth of -1% a year, a 5-year average ROIC of 10%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 279% above the current price.
About Braskem SA
Braskem SA is listed in the US and classified in major chemicals. Revenue went from $11.8B in 2015 to $12.5B in 2025, growth of about 0.5% a year. It was profitable in 4 of the last 10 years in our data.
Score: 0.2 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.9B | $12.5B | $12.5B | $14.5B | $18.3B | $19.0B | $11.3B | $13.0B | $14.9B | $14.9B | $14.6B |
| Net income | -$1.2B | -$1.7B | -$1.8B | -$944M | -$64M | $2.5B | -$1.3B | -$632M | $729M | $1.2B | -$126M |
| Free cash flow | — | -$1.3B | -$214M | -$1.4B | $776M | $2.0B | $680M | -$104M | $1.7B | $57M | $575M |
| EPS (diluted) | $-2.92 | $-4.38 | $-4.59 | $-2.37 | $-0.16 | $6.30 | $-3.23 | $-1.59 | $1.83 | $2.93 | $-0.32 |
| Net margin | -9.0% | -14.0% | -14.6% | -6.5% | -0.4% | 13.2% | -11.4% | -4.9% | 4.9% | 7.8% | -0.9% |
| ROIC | — | — | -1.5% | -4.8% | 7.8% | 47.3% | -0.1% | 0.3% | 21.0% | 23.0% | 18.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Braskem SA stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 279% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Braskem SA pay a dividend?
Not currently.
Is Braskem SA a good stock to buy?
We do not give buy or sell advice. Braskem SA scores 0.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.